Apnimed achieved positive results for its first oral pill for treating sleep apnea in a Phase 3 clinical trial. The pill is taken just before bedtime to help keep a person’s airway open.
It could be a game-changer for those with sleep apnea – the current treatment involves putting on a face mask connected to a Continuous Positive Airway Pressure (CPAP) machine, which keeps airways open by forcing air into them. The machines are effective, but they are noisy and can be uncomfortable, so many end up abandoning them, leaving them feeling exhausted, irritable, and unfocused during the day.
Read The New York Times article.
Sources:
• TLDR. (2025, July 30). TLDR Newsletter. https://a.tldrnewsletter.com/web-version?ep=1&lc=f5cb7e17-003d-11ed-9258-0241b9615763&p=54cdb09e-6d20-11f0-9655-8f67710f0c83&pt=campaign&t=1753873069&s=4f69e8b3c2f01f0fac9092a03cbbb87e01ad896cb1c4887f0a66736d75e7a290
• Hopkins Legaspi, C. (2025, July 23). A pill for sleep apnea could be on the horizon. The New York Times. https://www.nytimes.com/2025/07/23/well/apnimed-sleep-apnea-clinical-trial-ad109.html
